Safety data from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL).
2016 ◽
Vol 34
(15_suppl)
◽
pp. 9525-9525
◽
Keyword(s):
2009 ◽
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. e21058-e21058
2013 ◽
Vol 36
(3)
◽
pp. 215-222
◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 13
(9)
◽
pp. 1165-1173
◽
Keyword(s):